Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2025-12-25 @ 3:45 PM
Study NCT ID:
NCT00971659
Status:
COMPLETED
Last Update Posted:
2009-09-04
First Post:
2009-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
49/0316-Adjunct
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Christoph Kapitza, MD
Old Organization:
Profil Institut für Stoffwechselforschung GmbH
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |